Summary Slide.png (68.79 kB)

Characteristics of Patients with Type 1 or Type 2 Diabetes Receiving Insulin Glargine U300 – An Analysis of 7,268 Patients Based on the DPV and DIVE Registries

Download (68.79 kB)
figure
posted on 15.05.2019 by Gesine van Mark, Stefanie Lanzinger, Stefan Sziegoleit, Franz Josef Putz, Mesut Durmaz, Michaela Borscheller, Thomas Danne, Jochen Seufert, Reinhard W. Holl, Peter Bramlage

Full copyright for enhanced digital features is owned by the authors.


Provide enhanced digital features for this article
If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact adisrapidplus@springer.com.

The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.

Other enhanced features include, but are not limited to:
• Slide decks
• Videos and animations
• Audio abstracts
• Audio slides

Funding

German Centre for Diabetes Research (DZD) (01GI1106), the European Foundation for the Study of Diabetes (EFSD) and the German Diabetes Society (DDG). The DIVE registry (organized as Diabetes Agenda 2010 GmbH, Berlin, Germany) received funding from Sanofi, AstraZeneca, Bayer, and Abbott and was conducted under the auspices of diabetesDE.

History

Licence

Exports